Introduction
============

Deep surgical site infection (DSSI) after open induction internal fixation (ORIF) is a serious complication for traumatic limb fracture surgery, and if not promptly diagnosed or managed, it often leads to catastrophic consequences such as amputation and even death.[@b1-idr-11-2533] Although diagnostic examinations (including laboratory tests, imaging modalities, and pathogen cultures) exist, rapid, cheap, and accurate diagnosis remains challenging for many patients with infections.[@b2-idr-11-2533] Complete blood count (CBC), one of the most common routine preoperative tests, is frequently used by surgeons to assess inflammatory pathologies. Orthopedists often pay attention to white blood cell (WBC) count and neutrophil count in CBC to diagnose or monitor infections; however, their sensitivity and specificity are very low in fracture patients.[@b2-idr-11-2533],[@b3-idr-11-2533] Besides WBC count and neutrophil count, recent studies gradually focus on the role of platelet indices including platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW) in diagnosing infections such as acute appendicitis, ventriculo-peritoneal shunt infection, and urinary tract infection.[@b4-idr-11-2533]--[@b7-idr-11-2533] To our knowledge, there are no studies conducted examining the diagnosis of DSSI after ORIF for traumatic limb fractures using platelet indices. In this study, we aim to determine whether PDW, PLT, and MPV could be used for the diagnosis of such DSSI.

Patients and methods
====================

Patients
--------

A case--control study was performed. Between January 2011 and December 2017, a total of 73 patients with infections after ORIF were admitted at the Department of Orthopedics, The Affiliated Drum Tower Hospital of Nanjing University Medical School. DSSI was classified when both of the following criteria were met at the same time: clinical signs of a surgical site infection and positive bacterial cultures taken from the secreting wound.[@b8-idr-11-2533] Patients were excluded from the study for 1) age ≤18 years; 2) antibiotics or other treatments given before; 3) having acute or chronic infectious disease, comorbid conditions (cardiac, respiratory, renal, endocrinal, and vascular disease, cancer, etc.), hematological disease and blood transfusion within the last year for any reason; 4) having other organs' injuries such as brain, liver, and spleen; and 5) using ongoing medication (analgesics, oral contraceptives, antimetabolites, etc.). As a result, 29 patients per group were enrolled in this study. The control group was matched for age (±3 years), gender (male/female: 26/3), and fracture type (the same fracture type according to \[Association for the Study of Internal Fixation; AO\] classification) as closely as possible to patients with DSSI. The collection of patients' blood and all protocols or experiments were undertaken with the written informed consent of patients and with approval from the Ethics Committee of The Affiliated Drum Tower Hospital of Nanjing University Medical School. Our studies were conducted in compliance with the Declaration of Helsinki.

Blood test
----------

All blood samples (1.5 mL for each patient) were obtained from a peripheral vein on the day of admission and stored in tubes containing EDTA and assayed automatically using internationally certified devices (XE-5000; Sysmex, Japan). The reference values in The Affiliated Drum Tower Hospital of Nanjing University Medical School laboratory were (3.5-- 9.5)×10^9^/μL for WBC count, (1.8--6.3)×10^9^/μL for neutrophil count, 40--70% for neutrophil percentage, (181--300)×10^9^/μL for PLT, 9.4--12.5 fL for MPV, and 15.5--18.1% for PDW. All results were approved by an independent biochemistry expert who was blind to the patients' histories. According to our clinical experiences, if the values of blood test were to high or low, the test would be repeated again to avoid measurement error.

Statistical analyses
--------------------

Statistical analyses were performed, using the SPSS for Windows Version 18.0 (SPSS Inc., Chicago, IL, USA). Categorical variables are shown as frequencies and continuous variables were expressed as mean ± SD. The paired *t*-test was used for continuous variables. Chi-squared test was used to analyze categorical variables. To establish the predictive value of the parameters for diagnosing DSSI, receiver-operating characteristic (ROC) curves were analyzed. The areas under the ROC curves (AUC), the specificity and sensitivity were calculated and the optimal cutoff point from the study was the threshold leading to the maximum summation of sensitivity and specificity (the Youden index).[@b9-idr-11-2533] All differences were considered significant at a value of *P*\<0.05.

Results
=======

Twenty-nine infected cases and matched-control patients were included in this study. The body mass index (case group: 23.0±3.7 vs control group: 23.1±3.1 kg/m^2^) and the smoking and drinking ratio distribution had no significant differences between two groups ([Table 1](#t1-idr-11-2533){ref-type="table"}, *P*\>0.05).

The comparisons of blood parameters between case and control group were given in [Table 2](#t2-idr-11-2533){ref-type="table"}. No significant differences were either detected in the WBC count, neutrophil count, neutrophil percentage, or MPV values between the two groups (*P*\>0.05). There were statistical differences in PLT and PDW between two groups (*P*\<0.05). The case group had a mean PLT of 303.00±139.27, and the control group had a mean PLT of 196.10±59.61 (10^9^/μL). The PLT values were significantly higher in the case group than in the control group (*P*=0.001). The PDW values of the case and control groups were 11.77±2.71 and 13.19±2.39%, respectively. The PDW values were significantly lower in the case group (*P*=0.001).

For ROC analysis, using a cutoff value for PLT at 215.50 (10^9^/μL), the sensitivity, specificity, and positive predictive value (PPV) were 79.3, 72.4, and 74.2%; using a cutoff value for PDW at 10.35 (%), the sensitivity, specificity, and PPV was 37.9, 96.6, and 91.8% for the prediction of DSSI ([Table 3](#t3-idr-11-2533){ref-type="table"}). The PLT ROC analysis curves yielded an AUC of 0.812 (95% CI: 0.700--0.924) in the prediction of developing DSSI ([Figure 1A](#f1-idr-11-2533){ref-type="fig"}). For the PDW analysis, ROC curves yielded an AUC of 0.697 (95% CI: 0.562--0.832) in predicting the development of DSSI ([Figure 1B](#f1-idr-11-2533){ref-type="fig"}). At last, PLT (215.50\>10^9^/μL) and PDW (\<10.35%) were combined with logistic regressions to make ROC analysis. The sensitivity, specificity, PPV, and AUC were 72.4, 82.8, 80.8, and 0.817 (95% CI: 0.704--0.930) ([Table 3](#t3-idr-11-2533){ref-type="table"} and [Figure 1C](#f1-idr-11-2533){ref-type="fig"}).

Discussion
==========

DSSI is a dreaded complication after ORIF for traumatic limb fractures. Mild infection may delay fracture healing and prolong hospital stay, while severe infection often causes amputation or even death.[@b1-idr-11-2533] Early detection of DSSI is the first step to prevent or decrease its damage. Although some diagnostic methods are used to help diagnose DSSI, complete blood cell test is still the easiest, cheapest, and fastest one. In this study, we first revealed that platelet indices including PLT (\>215.50×10^9^/μL) and PDW (\<10.35%) could predict DSSI after ORIF for traumatic limb fractures.

WBC and neutrophil are the most commonly inflammatory marker, and their changes are usually used to indicate the onset of infectious disease. However, WBC and neutrophil are affected by many factors such as physiological stress, treatment, and trauma.[@b3-idr-11-2533],[@b8-idr-11-2533] Especially in fracture patients, the increase in WBC and neutrophil often appears. Considering DSSI is an inflammatory process, we also compared WBC and neutrophil parameters between case and control groups. Consistent with previous studies, there were no significant differences of WBC count, neutrophil count, and neutrophil percentage between two groups.[@b2-idr-11-2533] Hence. it was not necessary to further make ROC analysis.

Platelets, the small, anucleate cell fragments circulating in blood, play a basic role in hemostasis and thrombosis.[@b10-idr-11-2533] In recent years, platelets have been emphasized with respect to some infections and inflammatory diseases.[@b4-idr-11-2533]--[@b7-idr-11-2533],[@b10-idr-11-2533]--[@b12-idr-11-2533] Platelet indices including MPV, PLT, and PDW are the most common used parameters and can be easily examined in CBC. MPV represents the average size of platelets and correlates with platelet function and activation.[@b13-idr-11-2533] Larger platelets are metabolically and enzymatically more active in inflammatory process.[@b10-idr-11-2533] PDW, an index of platelet size heterogeneity, is also known as the volume change coefficient and represents heterogenic demarcation of megakaryocytes rather than the aging of circulating throm-bocytes.[@b7-idr-11-2533] Increased PDW levels indicate platelets swelling, destruction, and immaturity.[@b13-idr-11-2533]

In different infections or inflammatory diseases, platelet indices had different changes. For example, MPV levels were higher in urinary tract infection but lower in acute appendicitis.[@b6-idr-11-2533],[@b7-idr-11-2533] PDW levels were increased in acute appendicitis while reduced in invasive fungal disease.[@b7-idr-11-2533],[@b11-idr-11-2533] In the current study, we first found that there were significant correlations between platelet indices (PLT and PDW) with DSSI. PDW levels were reduced while PLT levels were increased in patients with DSSI (*P*\<0.05). However, there were no differences in MPV between two groups. We speculated that at the onset of DSSI, large platelets initiated to play an antibacterial role and be gradually reduced while megakaryocytes had not yet been stimulated to release large platelets from bone marrow. Thus, PDW seems to have been decreased in DSSI patients. In contrast, the infection could promote the inflammation phase interleukins releasing, such as interlecukin-1 and interlecukin-6, thus enhancing bone marrow activity.[@b14-idr-11-2533] Thrombocytosis may occur after bone marrow activity stimulated, which may be the reason for PLT levels' increase in DSSI patients.

In the current trial, the values of sensitivity and specificity of PLT in our study, 79.3 and 72.4%, respectively, are relatively moderate. Meanwhile, the best cutoff point of 10.35% for PDW in the diagnosis of DSSI had a low sensitivity of 37.9% but a high specificity of 96.6%. Explanation for PDW's low sensitivity found in our study may be attributed to our strict inclusion criteria and small sample size. Due to the small sample size, the number of patients with PDW \<10.35% was 1 in the control group and 11 in the case group and the proportion of such patients was only 26.1% in the sample. Therefore, the low sensitivity 37.9% of PDW might cause by the rareness of PDW \<10.35% in this study. However, the PPV (91.8% when PDW \<10.35%) was obviously higher than 74.2% when PLT \>215.5 (10^9^/μL). Hence, the high PPV indicated that PDW could be very powerful to screen the true positives when its value was less than 10.35%. To DSSI, high PPV was very important for its early and exact diagnosis could strongly affect the patient\`s treatment and prognosis. Now that using PLT or PDW alone for diagnosis both had some disadvantages, we then made a combined ROC analysis with PLT and PDW. PDW in combination with PLT could make all the statistical indices in adequate and range. It is acknowledged that the platelet indices cannot be the sole diagnostic tool for DSSI. It must be very discreet to make such diagnosis, because once DSSI was diagnosed improperly, further treatments of DSSI such as large doses of antibiotics, debridement and hard removal might cause additional severe harm to patients. However, attempts to develop a diagnostic method with 100% specificity and sensitivity have failed so far.

Our study has some limitations: first, as an observational study, the diagnostic role of platelet indices in DSSI after ORIF requires to be investigated further in a prospective validation study. Second, due to the low morbidity rate of DSSI in our department, the number of patients was not many. Multicenter prospective studies with large sample size are necessary in the future.

Conclusion
==========

Using the PLT and PDW simultaneously could make all the statistical indices in adequate range including specificity, sensitivity, PPV, and AUC. Hence, it was recommended that both PDW in combination with PLT should be used for the diagnosis of DSSI after ORIF for traumatic limb fractures. Nevertheless, diagnosis of DSSI should always be combined with clinical, laboratory, and radiologic evaluations. If patients were combined with positive clinical signs, symptoms, or other laboratory tests (erythrocyte sedimentation rate and C-reactive protein), DSSI should be highly suspected when PLT \>215.50×10^9^/μL and PDW \<10.35%.
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![The ROC curves for the optimal cutoff value of platelet indices.\
**Notes:** (**A**) The ROC curve for PLT (larger values indicate infection). (**B**) The ROC curve for PDW (smaller values indicate infection). (**C**) The ROC curve for PDW in combination with PLT.\
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###### 

The demographics between case and control groups

                                                             Cases (n=29)   Controls (n=29)   *P*-value
  ---------------------------------------------------------- -------------- ----------------- --------------------------------------------------
                                                                                              
  BMI (kg/m^2^)[a](#tfn2-idr-11-2533){ref-type="table-fn"}   23.0±3.7       23.1±3.1          0.895
  Daily drinker (yes/no)                                     8/21           10/11             0.232[b](#tfn3-idr-11-2533){ref-type="table-fn"}
  Current smoker (yes/no)                                    5/24           8/21              0.530[b](#tfn3-idr-11-2533){ref-type="table-fn"}

**Notes:** *P*\<0.05 indicated significances.

Values are presented as mean ± SD.

Fisher's exact test.

**Abbreviation:** BMI, body mass index.

###### 

Comparison of blood parameters between case and control groups

                                Case group n=29, mean ± SD   Control group n=29, mean ± SD   Mean difference   95% CI of mean difference   *P*-value
  ----------------------------- ---------------------------- ------------------------------- ----------------- --------------------------- -----------
                                                                                                                                           
  WBC count (10^9^/μL)          7.72±2.79                    8.48±2.63                       0.75              −0.70--2.20                 0.298
  Neutrophil count (10^9^/μL)   5.25±2.93                    5.90±2.49                       0.73              −0.84--2.14                 0.382
  Neutrophil percentage         65.16±11.37                  68.91±11.69                     3.75              −3.48--10.97                0.297
  MPV (fL)                      10.28±1.28                   10.81±1.11                      0.53              −0.079--1.15                0.085
  PLT (10^9^/μL)                303.00±139.27                196.10±59.61                    --106.90          −164.63-- −49.15            0.001
  PDW (%)                       11.77±2.71                   13.19±2.39                      1.80              0.77--2.83                  0.001

**Note:** *P*\<0.05 indicated significant differences.

**Abbreviations:** MPV, mean platelet volume; PDW, platelet distribution width; PLT, platelet count; WBC, white blood cell.

###### 

Results of ROC analysis for blood parameters

                   Cutoff point   Sensitivity (%)   Specificity (%)   AUC     PPV (%)   Asymptomatic 95% CI lower/upper bound
  ---------------- -------------- ----------------- ----------------- ------- --------- ---------------------------------------
                                                                                        
  PLT (10^9^/μL)   215.50         79.3              72.4              0.812   74.2      0.700--0.924
  PDW (%)          10.35          37.9              96.6              0.697   91.8      0.562--0.832
  PLT + PDW                       72.4              82.8              0.817   80.8      0.704--0.930

**Abbreviations:** AUC, areas under the ROC curves; PDW, platelet distribution width; PLT, platelet count; PPV, positive predictive value; ROC, receiver-operating characteristic.
